Advertisement

Topics

Cellerant Therapeutics, Inc. Awarded $6.86 Million Grant From To Support Development Of Novel Antibody-Drug Conjugate For AML

20:00 EDT 21 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Cellerant Therapeutics, Inc. Awarded $6.86 Million Grant From To Support Development Of Novel Antibody-Drug Conjugate For AML

NEXT ARTICLE

More From BioPortfolio on "Cellerant Therapeutics, Inc. Awarded $6.86 Million Grant From To Support Development Of Novel Antibody-Drug Conjugate For AML"

Advertisement
Quick Search
Advertisement
Advertisement